FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.2510
+0.0050 (2.03%)
At close: Feb 13, 2026, 4:00 PM EST
0.2669
+0.0159 (6.33%)
After-hours: Feb 13, 2026, 6:51 PM EST
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $16.7 million as of February 13, 2026. Its market cap has decreased by -71.50% in one year.
Market Cap
16.70M
Enterprise Value
18.94M
1-Year Change
-71.50%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $16.70M, a decrease of -98.23%. That is a compound annual growth rate of -86.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 16.70M | 11.61% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 17.76M |
| CASI Pharmaceuticals | 17.47M |
| IN8bio | 17.38M |
| Lunai Bioworks | 17.21M |
| Pasithea Therapeutics | 16.40M |
| Klotho Neurosciences | 16.24M |
| Citius Pharmaceuticals | 15.89M |
| Intensity Therapeutics | 15.85M |